Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...

BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival ...

T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in ...

Phone calls to follow up with patients with locally advanced esophageal squamous cell carcinoma while at home may reduce AEs ...

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...

Treosulfan plus fludarabine was approved by the FDA for children and adults with AML or MDS before allogenic hematopoietic ...

ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer ...

Findings from this survey also demonstrated that 23% of providers were comfortable with interpreting biomarker testing ...

Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.

Significant improvements in skin toxicity were observed by week 6 in all patients treated with HT-001 in the phase 2a ...